Alerus Financial’s GSK GSK Stock Holding History

Alerus Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.1K	Hold	364	–	–	﹤0.01%	350
2025 Q4	$17.9K	Hold	364	–	–	﹤0.01%	305
2025 Q3	$15.7K	Sell	364 -895	-71%	-$35K	﹤0.01%	340
2025 Q2	$48.3K	Buy	+1,259	New	+$48.1K	﹤0.01%	247
2021 Q2	–	Sell	-5,339	Closed	-$238K	–	195
2021 Q1	$238K	Sell	5,339 -76,956	-94%	-$3.49M	0.03%	175
2020 Q4	$3.79M	Sell	82,295 -5,518	-6%	-$253K	0.38%	68
2020 Q3	$4.13M	Buy	87,813 +14,884	+20%	+$746K	0.47%	53
2020 Q2	$3.72M	Buy	72,929 +10,204	+16%	+$524K	0.44%	66
2020 Q1	$2.97M	Buy	62,725 +16,168	+35%	+$862K	0.41%	70
2019 Q4	$2.73M	Buy	46,557 +6,507	+16%	+$362K	0.31%	81
2019 Q3	$2.14M	Buy	40,050 +2,457	+7%	+$126K	0.28%	83
2019 Q2	$1.88M	Buy	37,593 +1,279	+4%	+$64.2K	0.25%	87
2019 Q1	$1.9M	Buy	36,314 +946	+3%	+$47.3K	0.26%	84
2018 Q4	$1.69M	Buy	35,368 +15,557	+79%	+$766K	0.26%	84
2018 Q3	$995K	Buy	19,811 +753	+4%	+$38.3K	0.14%	100
2018 Q2	$960K	Buy	+19,058	New	+$960K	0.14%	100

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alerus Financial's GSK Position: Q1 2026 in Review

Alerus Financial held its GSK (GSK) position steady in Q1 2026 at 364 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Alerus Financial first reported a position in GSK in Q2 2018 and has held it in 16 quarters since. The position peaked at $4.13M in Q3 2020. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Alerus Financial held 364 shares of GSK worth $20.1K as of Q1 2026.
Alerus Financial left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of Alerus Financial's portfolio in Q1 2026, its #350 holding.
Alerus Financial first reported a position in GSK in Q2 2018 and has held it in 16 quarters since.
Alerus Financial's GSK position peaked at $4.13M in Q3 2020.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.